Tissue-transglutaminase contributes to neutrophil granulocyte differentiation and functions

Blood

Volumn 108, Issue 6, 2006, Pages 2045-2054

  Balajthy, Zoltán ^a   Csomós, Krisztián ^b   Vámosi, György ^b   Szántó, Attila ^b   Lanotte, Michel ^b   Fésüs, László ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; DANSYLCADAVERINE; NITROBLUE TETRAZOLIUM; NUCLEAR PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SUPEROXIDE;

ANIMAL CELL; ARTICLE; BLOOD CELL; CELL DIFFERENTIATION; CELL ISOLATION; CELL MATURATION; CELLULAR DISTRIBUTION; CHROMATIN; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; ENZYME DEGRADATION; ENZYME INDUCTION; ENZYME LOCALIZATION; ENZYME SUBUNIT; EXTRACELLULAR MATRIX; GENE EXPRESSION; GRANULOCYTE; GRANULOCYTE FUNCTION; INFLAMMATION; LEUKOCYTE FUNCTION; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL COUNT; NONHUMAN; PERITONEAL CAVITY; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; WILD TYPE;

EID: 33748677687     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2004-02-007948     Document Type: Article

References (57)

1. Folk JE. Transglutaminases. Annu Rev Biochem. 1980;49:517-537.
2. Thomazy V, Fesus L. Differential expression of tissue transglutaminase in human cells: an immunohistochemical study. Cell Tissue Res. 1989;255:215-224.
3. Fesus L, Piacentini M. Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci. 2002;27:534-539.
4. Akimov SS, Belkin AM. Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin. Blood. 2001;98:1567-1576.
5. Balklava Z, Verderio E, Collighan R, Gross S, Adams J, Griffin M. Analysis of tissue transglutaminase function in the migration of Swiss 3T3 fibroblasts: the active-state conformation of the enzyme does not affect cell motility but is important for its secretion. J Biol Chem. 2002;277:16567-16575.
6. Haroon ZA, Hettasch JM, Lai TS, Dewhirst MW, Greenberg CS. Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis. FASEB J. 1999;13:1787-1795.
7. Aeschlimann D, Thomazy V. Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases. Connect Tissue Res. 2000;41:1-27.
8. Nakaoka H, Perez DM, Beak KJ, et al. GTP-binding protein with transglutaminase activity and receptor signaling function. Science. 1994;264:1593-1596.
9. Chen S, Lin F, Iismaa S, Lee KN, Birckbichler PJ, Graham RM. Alpha1-adrenergic receptor signaling via Gh is subtype-specific and independent of its transglutaminase activity. J Biol Chem. 1996;271:32385-32391.
10. Dudek SM, Johnson GV. Transglutaminase facilitates the formation of polymers of the beta-amyloid peptide. Brain Res. 1994;651:129-133.
11. Dieterich W, Ehnis T, Bauer M, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med. 1997;3:797-801.
12. Bernassola F, Federici M, Corazzari M, et al. Role of transglutaminase 2 in glucose tolerance: knockout mice studies and a putative mutation in a MODY patient. FASEB J. 2002;16:1371-1378.
13. -/- mice reveal a phagocytosis-associated crosstalk between macrophages and apoptotic cells. Proc Natl Acad Sci U S A. 2003;100:7812-7817.
14. Nanda N, Iismaa SE, Owens WA, Husain A, Mackay F, Graham RM. Targeted inactivation of Gh/tissue transglutaminase II. J Biol Chem. 2001;276:20673- 20678.
15. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol. 2003;3:710-720.
16. Belaaouaj A. Neutrophil elastase-mediated killing of bacteria: lessons from targeted mutagenesis. Microbes Infect. 2002;12:1259-1264.
17. Lopez-Boado YS, Espinola M, Bahr S, Belaaouaj A. Neutrophil serine proteinases cleave bacterial flagellin, abrogating its host response-inducing activity. J Immunol. 2004;172:509-515.
18. Ellison RT III, Giehl TJ. Killing of gram-negative bacteria by lactoferrin and lysozyme. J Clin Invest. 1991;88:1080-1091.
19. Hampton MB, Kettle AJ, Winterbourn CC. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood. 1998;92:3007-3017.
20. Huang ME, Ye YC, Chen SR, et al. Use of all trans-retinoic acid in the treatment of acute promyelocytic leukemia. Blood. 1988;72:567-572.
21. Simon HU. Neutrophil apoptosis pathways and their modifications in inflammation. Immunol Rev. 2003;193:101-110.
22. Seely AJE, Pascual JL, Christou NV. Science review: cell membrane expression (connectivity) regulates neutrophil delivery, function and clearance. Critical Care. 2003;7:291-307.
23. Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F, Berger R. NB4, a maturation inducible cell line with t(15;17)-marker isolated from a human acute promyelocytic leukemia (M3). Blood. 1991;77:1080-1086.
24. Benoit GR, Flexor M, Besancon F, et al. Autonomous rexinoid death signaling is suppressed by converging signaling pathways in immature leukemia cells. Mol Endocrinol. 2001;15:1154-1169.
25. Benoit G, Altucci L, Flexor M, et al. RAR-independent RXR signaling induces t(15;17) leukemia cell maturation. EMBO J. 1999;18:7011-7018.
26. De Laurenzi V, Melino G. Gene disruption of tissue transglutaminase. Mol Cell Biol. 2001;21:148-155.
27. Tarcsa E, Fesus L. Determination of epsilon (gamma-glutamyl)lysine crosslink in proteins using phenylisothiocyanate derivatization and high-pressure liquid chromatographic separation. Anal Biochem. 1990;186:135-140.
28. Dahlgren C, Karlsson A. Respiratory burst in human neutrophils. J Immunol Methods. 1999;232:3-14.
29. Nishinaka Y, Aramaki Y, Yoshida H, Masuya H, Sugawara T, Ichimori Y. A new sensitive chemiluminescence probe, L-012, for measuring the production of superoxide anion by cells. Biochem Biophys Res Commun. 1993;193:554-559.
30. Lennon G, Auffray C, Polymeropoulos M, Soares MB. The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression. Genomics. 1996;33:151-152.
31. Benedetti L, Grignani F, Scicchitano BM, et al. Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RAR alpha-mediated increase of type II transglutaminase. Blood. 1996;87:1939-1950.
32. Wan KM, Nickerson JA, Krockmalnic G, Penman S. The nuclear matrix prepared by amine modification. Proc Natl Acad Sci U S A. 1999;96:933-938.
33. Anderson KL, Smith KA, Perkin H, et al. PU.1 and the granulocyte- and macrophage colony-stimulating factor receptors play distinct roles in late-stage myeloid cell differentiation. Blood. 1999;94:2310-2318.
34. Peng X, Zhang Y, Zhang H, et al. Interaction of tissue transglutaminase with nuclear transport protein importin-alpha3. FEBS Lett. 1999;446:35-39.
35. Lesort M, Attanavanich K, Zhang J, Johnson GVW. Distinct nuclear localization and activity of tissue transglutaminase. J Biol Chem. 1999;273:11991-11994.
36. Singh US, Erickson JW, Cerione RA. Identification and biochemical characterization of an 80 kilodalton GTP-binding/transglutaminase from rabbit liver nuclei. Biochemistry. 1995;34:15863-15871.
37. Lesort M, Chun W, Johnson GV, Ferrante RJ. Tissue transglutaminase is increased in Huntington's disease brain. J Neurochem. 1999;73:2018-2027.
38. Shimizu T, Takao T, Hozumi K, et al. Structure of a covalently cross-linked form of core histones present in starfish sperm. Biochemistry. 1997;36:12071-12079.
39. Oliverio S, Amendola A, Di Sano F, et al. Tissue transglutaminase- dependent posttranslational modification of the retinoblastoma gene product in promonocytic cells undergoing apoptosis. Mol Cell Biol. 1997;17:6040-6048.
40. Han JA, Park SC. Transglutaminase-dependent modulation of transcription factor Sp1 activity. Mol Cells. 2000;10:612-618.
41. Shimada J, Suzuki Y, Kim SJ, Wang PC, Matsumura M, Kojima S. Transactivation via RAR/RXR-Sp1 interaction: characterization of binding between Sp1 and GC box motif. Mol Endocrinol. 2001;15:1677-1692.
42. Mishra S, Murphy LJ. Tissue transglutaminase has intrinsic kinase activity: identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase. J Biol Chem. 2004;279:23863-23868.
43. Akimov SS, Krylov D, Fleischman LF, Belkin AM. Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol. 2000;148:825-838.
44. Wang Y, Devereux W, Stewart TM, Casero RA. Polyamine-modulated factor 1 binds to the human homologue of the 7a subunit of the Arabidopsis COP9 signalosome: implications in gene expression. Biochem J. 2002;366:79-86.
45. Mohan K, Pinto D, Issekutz TB. Identification of tissue transglutaminase as a novel molecule involved in human CD8+ T cell transendothelial migration. J Immunol. 2003;171:3179-3186.
46. Stephens P, Grenard P, Aeschlimann P, et al. Crosslinking and G-protein functions of transglutaminase 2 contribute differentially to fibroblast wound healing responses. J Cell Sci. 2004;117:3389-3403.
47. Kang SK, Yi KS, Kwon NS, et al. Alpha1B-adrenoceptor signaling and cell motility: GTPase function of Gh/transglutaminase 2 inhibits cell migration through interaction with cytoplasmic tail of integrin alpha subunits. J Biol Chem. 2004;279:36593-36000.
48. Esposito C, Caputo I. Mammalian transglutaminases: identification of substrates as a key to physiological function and physiopathological relevance. FEBS J. 2005;272:615-631.
49. Mhaouty-Kodja S. Ghalpha/tissue transglutaminase 2: an emerging G protein in signal transduction. Biol Cell. 2004;96:363-367.
50. Rodolfo C, Mormone E, Matarrese P, et al. Tissue transglutaminase is a multifunctional BH3-only protein. J Biol Chem. 2004;279:54783-54792.
51. Piredda L, Farrace MG, Lo Bello M, et al. Identification of tissue transglutaminase binding proteins in neural cells committed to apoptosis. FASEB J. 1999;13:355-364.
52. Feng JF, Gray CD, Im MJ. Alpha 1B-adrenoceptor interacts with multiple sites of transglutaminase II: characteristics of the interaction in binding and activation. Biochemistry. 1999;38:2224-2232.
53. Nishi T, Shimizu N, Hiramoto M, et al. Spatial redox regulation of a critical cysteine residue of NF-kappa B in vivo. J Biol Chem. 2002;277:44548-44556.
54. Nardacci R, Lo Iacono O, Ciccosanti F, et al. Transglutaminase type II plays a protective role in hepatic injury. Am J Pathol. 2003;162:1293-1303.
55. Skill NJ, Johnson TS, Coutts IG, et al. Inhibition of transglutaminase activity reduces extracellular matrix accumulation induced by high glucose levels in proximal tubular epithelial cells. J Biol Chem. 2004;279:47754-47762.
56. Miele L. New weapons against inflammation: dual inhibitors of phospholipase A2 and transglutaminase. J Clin Invest. 2003;111:19-21.
57. Zhang Z, Vezza R, Plappert T, et al. COX-2-dependent cardiac failure in Gh/tTG transgenic mice. Circ Res. 2003;92:1153-1161.